252 related articles for article (PubMed ID: 26078808)
1. Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State.
Yanpanitch OU; Hatairaktham S; Charoensakdi R; Panichkul N; Fucharoen S; Srichairatanakool S; Siritanaratkul N; Kalpravidh RW
Oxid Med Cell Longev; 2015; 2015():537954. PubMed ID: 26078808
[TBL] [Abstract][Full Text] [Related]
2. Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients.
Morales NP; Rodrat S; Piromkraipak P; Yamanont P; Paiboonsukwong K; Fucharoen S
Biomed Pharmacother; 2022 Jan; 145():112381. PubMed ID: 34736078
[TBL] [Abstract][Full Text] [Related]
3. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids.
Kalpravidh RW; Siritanaratkul N; Insain P; Charoensakdi R; Panichkul N; Hatairaktham S; Srichairatanakool S; Phisalaphong C; Rachmilewitz E; Fucharoen S
Clin Biochem; 2010 Mar; 43(4-5):424-9. PubMed ID: 19900435
[TBL] [Abstract][Full Text] [Related]
4. Differentially expressed plasma proteins of β-thalassemia/hemoglobin E patients in response to curcuminoids/vitamin E antioxidant cocktails.
Panachan J; Chokchaichamnankit D; Weeraphan C; Srisomsap C; Masaratana P; Hatairaktham S; Panichkul N; Svasti J; Kalpravidh RW
Hematology; 2019 Dec; 24(1):300-307. PubMed ID: 30661467
[TBL] [Abstract][Full Text] [Related]
5. The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress.
Dissayabutra T; Tosukhowong P; Seksan P
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S317-21. PubMed ID: 16623048
[TBL] [Abstract][Full Text] [Related]
6. Role of curcuminoids in ameliorating oxidative modification in β-thalassemia/Hb E plasma proteome.
Weeraphan C; Srisomsap C; Chokchaichamnankit D; Subhasitanont P; Hatairaktham S; Charoensakdi R; Panichkul N; Siritanaratkul N; Fucharoen S; Svasti J; Kalpravidh RW
J Nutr Biochem; 2013 Mar; 24(3):578-85. PubMed ID: 22818714
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
[TBL] [Abstract][Full Text] [Related]
8. IMPAIRED ENDOTHELIAL FUNCTION IN PEDIATRIC HEMOGLOBIN E/β-THALASSEMIA PATIENTS WITH IRON OVERLOAD.
Aphinives C; Kukongviriyapan U; Jetsrisuparb A; Kukongviriyapan V; Somparn N
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1454-63. PubMed ID: 26466432
[TBL] [Abstract][Full Text] [Related]
9. Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients.
Hatairaktham S; Masaratana P; Hantaweepant C; Srisawat C; Sirivatanauksorn V; Siritanaratkul N; Panichkul N; Kalpravidh RW
Ann Hematol; 2021 Apr; 100(4):891-901. PubMed ID: 33388858
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients.
Akrawinthawong K; Chaowalit N; Chatuparisuth T; Siritanaratkul N
Hematology; 2011 Mar; 16(2):113-22. PubMed ID: 21418744
[TBL] [Abstract][Full Text] [Related]
11. Effect of coenzyme Q10 as an antioxidant in beta-thalassemia/Hb E patients.
Kalpravidh RW; Wichit A; Siritanaratkul N; Fucharoen S
Biofactors; 2005; 25(1-4):225-34. PubMed ID: 16873951
[TBL] [Abstract][Full Text] [Related]
12. Protection against oxidative stress in beta thalassemia/hemoglobin E erythrocytes by inhibitors of glutathione efflux transporters.
Muanprasat C; Wongborisuth C; Pathomthongtaweechai N; Satitsri S; Hongeng S
PLoS One; 2013; 8(1):e55685. PubMed ID: 23383265
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of oxidative stress-induced changes in thalassemic erythrocytes by vitamin E.
Das N; Das Chowdhury T; Chattopadhyay A; Datta AG
Pol J Pharmacol; 2004; 56(1):85-96. PubMed ID: 15047982
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant status in beta thalassemia major: a single-center study.
Waseem F; Khemomal KA; Sajid R
Indian J Pathol Microbiol; 2011; 54(4):761-3. PubMed ID: 22234105
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation and antioxidant status in beta-thalassemia.
Meral A; Tuncel P; Sürmen-Gür E; Ozbek R; Oztürk E; Günay U
Pediatr Hematol Oncol; 2000 Dec; 17(8):687-93. PubMed ID: 11127401
[TBL] [Abstract][Full Text] [Related]
16. Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia.
De Luca C; Filosa A; Grandinetti M; Maggio F; Lamba M; Passi S
Free Radic Res; 1999 Jun; 30(6):453-62. PubMed ID: 10400457
[TBL] [Abstract][Full Text] [Related]
17. Oxidative instability of hemoglobin E (β26 Glu→Lys) is increased in the presence of free α subunits and reversed by α-hemoglobin stabilizing protein (AHSP): Relevance to HbE/β-thalassemia.
Strader MB; Kassa T; Meng F; Wood FB; Hirsch RE; Friedman JM; Alayash AI
Redox Biol; 2016 Aug; 8():363-74. PubMed ID: 26995402
[TBL] [Abstract][Full Text] [Related]
18. Iron status and oxidative stress in beta-thalassemia patients in Jakarta.
Laksmitawati DR; Handayani S; Udyaningsih-Freisleben SK; Kurniati V; Adhiyanto C; Hidayat J; Kusnandar S; Dillon HS; Munthe BG; Wirawan R; Soegianto RR; Ramelan W; Freisleben HJ
Biofactors; 2003; 19(1-2):53-62. PubMed ID: 14757977
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.
Moayedi Esfahani BA; Reisi N; Mirmoghtadaei M
Hemoglobin; 2015; 39(2):75-80. PubMed ID: 25643967
[TBL] [Abstract][Full Text] [Related]
20. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.
Fibach E; Rachmilewitz EA
Ann N Y Acad Sci; 2010 Aug; 1202():10-6. PubMed ID: 20712766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
